Clinical Trial Update: Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial update reporting completion of a study to determine the optimal dosage of mosapride with probiotics for irritable bowel syndrome witho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Mosapride (mosapride)
• Probiotic formulation

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Irritable Bowel Syndrome Without Diarrhea | Phase 2 | Status: COMPLETED